132 related articles for article (PubMed ID: 3000164)
1. Immunocytochemical demonstration of growth hormone-releasing factor in gastrointestinal and pancreatic endocrine tumors.
Dayal Y; Lin HD; Tallberg K; Reichlin S; DeLellis RA; Wolfe HJ
Am J Clin Pathol; 1986 Jan; 85(1):13-20. PubMed ID: 3000164
[TBL] [Abstract][Full Text] [Related]
2. Growth-hormone-releasing factor immunoreactivity in human endocrine tumors.
Bostwick DG; Quan R; Hoffman AR; Webber RJ; Chang JK; Bensch KG
Am J Pathol; 1984 Nov; 117(2):167-70. PubMed ID: 6093542
[TBL] [Abstract][Full Text] [Related]
3. Multihormonal carcinoid tumor of the pancreas. Secreting growth hormone-releasing factor as a cause of acromegaly.
Berger G; Trouillas J; Bloch B; Sassolas G; Berger F; Partensky C; Chayvialle JA; Brazeau P; Claustrat B; Lesbros F
Cancer; 1984 Nov; 54(10):2097-108. PubMed ID: 6435852
[TBL] [Abstract][Full Text] [Related]
4. Acromegaly and Zollinger-Ellison syndrome secondary to an islet cell tumor: characterization and quantification of plasma and tumor human growth hormone-releasing factor.
Wilson DM; Ceda GP; Bostwick DG; Webber RJ; Minkoff JR; Pont A; Hintz RL; Bensch KG; Kraemer FB; Rosenfeld RG
J Clin Endocrinol Metab; 1984 Nov; 59(5):1002-5. PubMed ID: 6090497
[TBL] [Abstract][Full Text] [Related]
5. [Acromegaly, clinical expression of the production of growth hormone releasing factor in pancreatic tumors].
Sassolas G; Chayvialle JA; Partensky C; Berger G; Trouillas J; Berger F; Claustrat B; Cohen R; Girod C; Guillemin R
Ann Endocrinol (Paris); 1983; 44(6):347-54. PubMed ID: 6430207
[TBL] [Abstract][Full Text] [Related]
6. Human hypothalamic growth hormone releasing factor (GRF): evidence for two forms identical to tumor derived GRF-44-NH2 and GRF-40.
Böhlen P; Brazeau P; Bloch B; Ling N; Gaillard R; Guillemin R
Biochem Biophys Res Commun; 1983 Aug; 114(3):930-6. PubMed ID: 6412708
[TBL] [Abstract][Full Text] [Related]
7. Reversible sellar enlargement due to growth hormone-releasing hormone production by pancreatic endocrine tumors in a acromegalic patient with multiple endocrine neoplasia type I syndrome.
Ramsay JA; Kovacs K; Asa SL; Pike MJ; Thorner MO
Cancer; 1988 Jul; 62(2):445-50. PubMed ID: 2898285
[TBL] [Abstract][Full Text] [Related]
8. Immunohistological localization of growth hormone-releasing hormone in human tumors.
Asa SL; Kovacs K; Thorner MO; Leong DA; Rivier J; Vale W
J Clin Endocrinol Metab; 1985 Mar; 60(3):423-7. PubMed ID: 3919041
[TBL] [Abstract][Full Text] [Related]
9. Primary endocrine-secreting pancreatic tumors.
Macaron C
Am Fam Physician; 1980 Apr; 21(4):94-8. PubMed ID: 6103668
[TBL] [Abstract][Full Text] [Related]
10. Reduction of pituitary size by the somatostatin analogue SMS 201-995 in a patient with an islet cell tumour secreting growth hormone releasing factor.
Wilson DM; Hoffman AR
Acta Endocrinol (Copenh); 1986 Sep; 113(1):23-8. PubMed ID: 2876570
[TBL] [Abstract][Full Text] [Related]
11. [Immunohistochemical detection of growth hormone-releasing factor (GRF) in neuroendocrine tumors].
Gottschalk J; Rohde W
Acta Histochem Suppl; 1988; 35():207-12. PubMed ID: 2843943
[TBL] [Abstract][Full Text] [Related]
12. [Hormone immunocytochemical studies of 46 endocrine tumors of the pancreas in 24 patients].
Le Bodic MF; Cloarec D; Lehur PA; Visset J; Le Bodic L
Gastroenterol Clin Biol; 1986 Apr; 10(4):334-40. PubMed ID: 3013709
[TBL] [Abstract][Full Text] [Related]
13. Current status of the apudomas.
Welbourn RB
Ann Surg; 1977 Jan; 185(1):1-12. PubMed ID: 12724
[No Abstract] [Full Text] [Related]
14. Production and secretion of immunoreactive growth hormone-releasing factor by pheochromocytomas.
Sano T; Saito H; Yamasaki R; Hosoi E; Kameyama K; Saito S; Hirose T; Hizawa K
Cancer; 1986 May; 57(9):1788-93. PubMed ID: 2869833
[TBL] [Abstract][Full Text] [Related]
15. A rare cause of acromegaly: ectopic production of growth hormone-releasing factor by a bronchial carcinoid tumor.
Garcia-Luna PP; Leal-Cerro A; Montero C; Scheithauer BW; Campanario A; Dieguez C; Astorga R; Kovacs K
Surg Neurol; 1987 Jun; 27(6):563-8. PubMed ID: 3107152
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic lesions and hormonal profile of pancreatic tumors in multiple endocrine neoplasia type I. An immunocytochemical study of nine patients.
Klöppel G; Willemer S; Stamm B; Häcki WH; Heitz PU
Cancer; 1986 May; 57(9):1824-32. PubMed ID: 2420439
[TBL] [Abstract][Full Text] [Related]
17. The analysis of immunophenotype of gastrin-producing tumors of the pancreas and gastrointestinal tract.
Gurevich L; Kazantseva I; Isakov VA; Korsakova N; Egorov A; Kubishkin V; Bulgakov G
Cancer; 2003 Nov; 98(9):1967-76. PubMed ID: 14584081
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide 1 immunoreactivity in gastroentero-pancreatic endocrine tumors: a light- and electron-microscopic study.
Eissele R; Göke R; Weichardt U; Fehmann HC; Arnold R; Göke B
Cell Tissue Res; 1994 Jun; 276(3):571-9. PubMed ID: 8062345
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone-releasing hormone (GHRH)-secreting pancreatic tumor in a patient with multiple endocrine neoplasia type I.
Sano T; Yamasaki R; Saito H; Hirose T; Kudo E; Kameyama K; Hiraishi K; Saito S; Hizawa K
Am J Surg Pathol; 1987 Oct; 11(10):810-9. PubMed ID: 2889383
[TBL] [Abstract][Full Text] [Related]
20. Retrospective study of 77 pancreatic endocrine tumors using the immunoperoxidase method.
Mukai K; Grotting JC; Greider MH; Rosai J
Am J Surg Pathol; 1982 Jul; 6(5):387-99. PubMed ID: 6127037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
